This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Kindred Healthcare Chief Executive Officer Paul J. Diaz Testifies Before U.S. Senate Finance Committee

Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that Paul J. Diaz, Kindred’s Chief Executive Officer, testified before the U.S. Senate Finance Committee (the “Committee”).

Mr. Diaz was invited to testify at a hearing titled “Progress in Health Care Delivery: Innovations from the Field.” At the hearing, Mr. Diaz spoke about the need for collaboration, teamwork and alignment of interests in order to transform the nation’s healthcare delivery system to be more patient-centered, outcome-driven and cost effective, and the critical role post-acute care plays in such a system.

In oral testimony before the Committee, Mr. Diaz shared the Company’s experiences in testing new care models in different markets. Specifically, he stated, “Several years ago, Kindred and other providers began to develop the capabilities to meet the needs of patients throughout their entire episode of care to begin to address the shortcomings of the current silo-based system. So we set out to build the capabilities to deliver integrated post-acute care in local communities.”

Discussing the role of post-acute care in pursuing new care models, Mr. Diaz said, “We have to do a better job of coordinating care for patients – to improve quality and reduce costs – and tremendous opportunities exist as our patients leave hospitals, enter post-acute care settings, and ultimately transition home.”

Mr. Diaz’s written testimony, available at, provides detailed accounts of pilots where Kindred is collaborating with physicians, and acute care and managed care partners and testing new models of care delivery.

Reaffirming Kindred’s commitment to work with the Committee and other healthcare providers to transform the nation’s healthcare delivery system and to be part of the solution, Mr. Diaz remarked, “We can improve quality and reduce costs in the near term by re-shaping our delivery and payment systems. But investments in wellness and prevention, electronic health records, and care management offer longer term rewards.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs